Immune response to SARS-CoV-2 prior to vaccination among healthcare workers from Alto Paraná, Paraguay, a seroepidemiological study
Published 2024-07-17
How to Cite
Copyright (c) 2024 Arturo Ramón Vargas Correa, Nancy Segovia Coronel, Alexandra Clarissa Bayer, Eva Fabiana Mereles, Margarita Samudio, Andrea Giménez Ayala, Lorena Santacruz, Maria Leticia Ojeda, Ingrid Espinola, Roxana Jorgge

This work is licensed under a Creative Commons Attribution 4.0 International License.
Abstract
Background: Understanding the behavior of humoral response in COVID-19 continues to be a challenge to produce vaccines that provide long-lasting immunity. Aim: To describe the natural humoral response induced by SARS-CoV-2 among healthcare workers based on epidemiological and clinical profiles. Methods: Cross-sectional study in healthcare workers from public hospitals in the Department of Alto Paraná, Paraguay, 962 participants were recruited through consecutive sampling, using a questionnaire and blood sampling. Antibodies were determined by immunochromatography assay for detection of IgM and IgG and by SARS-CoV-2 IgG anti-spike capture ELISA method and factors associated with seropositivity were evaluated. Results: The overall seropositivity was 36.5% (95% CI: 33.4 – 39.5); 59.3% (n: 571) of respondents reported symptoms compatible with COVID-19 since the start of the pandemic and the date of blood draw, 44% (n: 251) of them tested positive; 10.4% (n: 100) who reported no history of symptoms tested positive. The factors associated with seropositivity were the presence of symptoms (p<0.0001); anosmia (p:0.011); to have a risk factor (p:0.036); working at the Presidente Franco District Hospital (p:0.016). No association with sociodemographic factors was observed. Seroprevalence in symptomatic participants varied according to the time elapsed from the onset of symptoms to serology: 34.3% (<15 days), 58.6 (15 - 90 days), 40.1% (>90 days). Conclusions: Clinical characteristics were mostly associated with seropositivity and seroprevalence in symptomatic participants varied according to the time elapsed from the onset of symptoms to serology.
